CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −1,125 | 0 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +1,125 | 1,125 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −21,250 | 0 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +21,250 | 21,250 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −175,000 | 0 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2018-08-29 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2018-08-29 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2018-08-29 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Returned to the company · Stock Option (Right to Buy) | −1,250 | 0 | ||
| 2018-08-29 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +1,250 | 1,250 | ||
| 2018-08-29 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Returned to the company · Stock Option (Right to Buy) | −12,500 | 0 |
Page 10 of 17 · 323 trades